Baseline Serum Testosterone in Men Treated with Androgen Deprivation Therapy and Radiotherapy for Localized Prostate Cancer

It is believed that men diagnosed with prostate cancer and a low baseline serum testosterone (BST) may have more aggressive disease and it is frequently recommended they forego testosterone replacement therapy. We used two large phase III trials involving androgen deprivation therapy (ADT) and radiotherapy (EBRT) to assess the significance of a BST.

read more